Cholera in pregnancy: Clinical and immunological aspects
- PMID: 26283553
- PMCID: PMC4830121
- DOI: 10.1016/j.ijid.2015.08.006
Cholera in pregnancy: Clinical and immunological aspects
Abstract
Background: The objective of this study was to examine the clinical and immunological features of cholera in pregnancy.
Methods: Women of reproductive age presenting to the icddr,b Dhaka hospital with cholera, and enrolled as part of a larger cohort study, were tested for pregnancy on admission. We compared initial clinical features and immune responses of pregnant patients with non-pregnant female patients at days 2, 7 and 21 after infection.
Results: Among reproductive age women enrolled between January 2001 and May 2006, 9.7% (14/144) were pregnant. The duration of diarrhoea prior to admission tended to be higher in pregnant compared to non-pregnant patients (p=0.08), but other clinical characteristics did not differ. Antibody responses to cholera toxin B subunit (CtxB), toxin-coregulated pilus A (TcpA), Vibrio cholerae lipopolysaccharide (LPS), and serum vibriocidal antibody responses, were comparable between pregnant and non-pregnant patients. There were no deaths among the pregnant cases or non-pregnant controls, and no adverse foetal outcomes, including stillbirths, during 21 days of follow up of pregnant cases.
Conclusions: To our knowledge, this is the first report of immune responses in pregnant women with cholera. We found that pregnant woman early in pregnancy has comparable clinical illness and subsequent immune responses compared to non-pregnant women. These findings suggest that the evaluation of safety and immunogenicity of oral cholera vaccines in pregnancy should be an area of future investigations.
Keywords: Cholera; Immune response; Pregnancy.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
There are no conflicts of interest by authors.
Similar articles
-
A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh.Pediatr Infect Dis J. 2008 Nov;27(11):986-92. doi: 10.1097/INF.0b013e3181783adf. Pediatr Infect Dis J. 2008. PMID: 18833030 Free PMC article.
-
Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers.Infect Immun. 2003 Aug;71(8):4808-14. doi: 10.1128/IAI.71.8.4808-4814.2003. Infect Immun. 2003. PMID: 12874365 Free PMC article.
-
Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh.Infect Immun. 2009 Sep;77(9):3850-6. doi: 10.1128/IAI.00369-09. Epub 2009 Jun 15. Infect Immun. 2009. PMID: 19528207 Free PMC article.
-
Pathogenic and vaccine significance of toxin-coregulated pili of Vibrio cholerae E1 Tor.J Biotechnol. 1999 Aug 20;73(2-3):109-17. doi: 10.1016/s0168-1656(99)00114-5. J Biotechnol. 1999. PMID: 10486921 Review.
-
[The immunology of cholera and the molecular biology of cholera toxin. Recent progress and future perspectives].Rev Alerg Mex. 1994 May-Jun;41(3):69-76. Rev Alerg Mex. 1994. PMID: 9377108 Review. Spanish.
Cited by
-
Effect of Diarrheal Illness During Pregnancy on Adverse Birth Outcomes in Nepal.Open Forum Infect Dis. 2019 Jan 14;6(2):ofz011. doi: 10.1093/ofid/ofz011. eCollection 2019 Feb. Open Forum Infect Dis. 2019. PMID: 30793004 Free PMC article.
-
Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era.Hum Vaccin Immunother. 2017 Mar 4;13(3):579-587. doi: 10.1080/21645515.2016.1245250. Hum Vaccin Immunother. 2017. PMID: 27813703 Free PMC article. Review.
-
Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.Curr Environ Health Rep. 2016 Sep;3(3):322-34. doi: 10.1007/s40572-016-0096-x. Curr Environ Health Rep. 2016. PMID: 27352014 Free PMC article. Review.
-
Cholera rages in Africa and the Middle East: A narrative review on challenges and solutions.Health Sci Rep. 2024 May 12;7(5):e2013. doi: 10.1002/hsr2.2013. eCollection 2024 May. Health Sci Rep. 2024. PMID: 38742091 Free PMC article. Review.
-
Diarrhea treatment center (DTC) based diarrheal disease surveillance in settlements in the wake of the mass influx of forcibly displaced Myanmar national (FDMN) in Cox's Bazar, Bangladesh, 2018.PLoS One. 2021 Aug 2;16(8):e0254473. doi: 10.1371/journal.pone.0254473. eCollection 2021. PLoS One. 2021. PMID: 34339419 Free PMC article. Clinical Trial.
References
-
- WHO. Cholera vaccines: WHO position paper. Wkly Epidemiol Rec. 2010;85(13):117–28. - PubMed
-
- Ali M, et al. The spatial epidemiology of cholera in an endemic area of Bangladesh. Soc Sci Med. 2002;55(6):1015–24. - PubMed
-
- Armenti VT, et al. Immunosuppression in pregnancy: choices for infant and maternal health. Drugs. 2002;62(16):2361–75. - PubMed
-
- Murtha AP, et al. Maternal serum cytokines in preterm premature rupture of membranes. Obstet Gynecol. 2007;109(1):121–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical